Imunon, Inc. (IMNN) stock
IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.63−0.01 (-1.22%)
Close on Nov 13, 2026Market cap $3.53MP/E –Yield –
Imunon profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Imunon's profit margin for the twelve months ending Dec 31, 2022 was -7179.6%. For fiscal 2022 it was -7179.6%, against -4153.9% the year before. The highest annual figure on record is -2376.7% in fiscal 2018.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -7179.6% | −3025.8 |
| FY2021 | Dec 31, 2021 | -4153.9% | +142.9 |
| FY2020 | Dec 31, 2020 | -4296.7% | −926.4 |
| FY2019 | Dec 31, 2019 | -3370.3% | −993.6 |
| FY2018 | Dec 31, 2018 | -2376.7% | +1703.8 |
| FY2017 | Dec 31, 2017 | -4080.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -10586.1% | −7209.1 |
| Q3 FY2022 | Sep 30, 2022 | -4918.6% | −590.2 |
| Q2 FY2022 | Jun 30, 2022 | -4834.3% | −475.6 |
| Q1 FY2022 | Mar 31, 2022 | -8379.5% | −3828.3 |
| Q4 FY2021 | Dec 31, 2021 | -3377.0% | −967.3 |
| Q3 FY2021 | Sep 30, 2021 | -4328.4% | +2128.8 |
| Q2 FY2021 | Jun 30, 2021 | -4358.7% | −84.4 |
| Q1 FY2021 | Mar 31, 2021 | -4551.2% | −505.7 |
| Q4 FY2020 | Dec 31, 2020 | -2409.7% | +72.5 |
| Q3 FY2020 | Sep 30, 2020 | -6457.3% | −2075.8 |
| Q2 FY2020 | Jun 30, 2020 | -4274.3% | +449.3 |
| Q1 FY2020 | Mar 31, 2020 | -4045.5% | −2151.5 |
| Q4 FY2019 | Dec 31, 2019 | -2482.2% | −6866.7 |
| Q3 FY2019 | Sep 30, 2019 | -4381.4% | −656.3 |
| Q2 FY2019 | Jun 30, 2019 | -4723.6% | +1860.8 |
| Q1 FY2019 | Mar 31, 2019 | -1894.0% | +1687.6 |
| Q4 FY2018 | Dec 31, 2018 | 4384.5% | +8129.1 |
| Q3 FY2018 | Sep 30, 2018 | -3725.1% | +812.0 |
| Q2 FY2018 | Jun 30, 2018 | -6584.4% | −2047.4 |
| Q1 FY2018 | Mar 31, 2018 | -3581.6% | +546.5 |
| Q4 FY2017 | Dec 31, 2017 | -3744.7% | – |
| Q3 FY2017 | Sep 30, 2017 | -4537.1% | – |
| Q2 FY2017 | Jun 30, 2017 | -4537.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -4128.1% | – |
See a number that looks wrong?